TAK — TAKEDA PHARMACEUTICAL CO LTD

Ownership history in Optas, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Optas, LLC reported a position in TAKEDA PHARMACEUTICAL CO LTD (TAK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2023 Q3)
Avg. % of fund
0.04%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 11,254 +1,096 +10.8% 0.03% $165K $14.64
2023 Q3 INITIATED 10,158 — — 0.05% $157K —
% of Fund (quarterly)    TAK price (monthly, adj. close)

Other funds also holding TAK

As of 2025 Q4 — sorted by position size

MANAGED ASSET PORTFOLIOS, LLC 3Y 7Y 2.82% Clean Yield Group 3Y 7Y 1.13% Legacy Wealth Asset Management, LLC 3Y 0.64% Gold Investment Management Ltd. 0.54% BRANDES INVESTMENT PARTNERS, LP 3Y 7Y 0.46% Carrera Capital Advisors 0.42% Keenan, LLC 0.25% Arjuna Capital 3Y 7Y 0.23% Murphy, Middleton, Hinkle & Parker, Inc. 3Y 7Y 0.23% Corient IA LLC 0.22%
← Back to Optas, LLC Holdings